Swipe or use the arrows to view product images.
Huaren Pharmaceutical/Mannitol Injection
| Price | $3.00 |
|---|---|
| Min Order | 10000 Bags |
| Availability | In Stock |
| Shipping From | Shandong, China |
| Popularity | 477 people viewed |
Model NO.:
3000ml
Application:
Surgery
Suitable for:
Elderly, Children, Adult
State:
Liquid
Type:
Inorganic Chemicals
Pharmaceutical Technology:
Chemical Synthesis
Drug Reg./Approval No.:
H20056726
Trademark:
Huaren
Transport Package:
Carton
Specification:
3000ml: 150g
Origin:
China
Product Description
Drug Name: Mannitol Injection
Main ingredients: D-Mannitol
Structural formula : C6H14O6
Mol wt: 182.17
Description: The product is clear colorless liquid.
Indaication:This product is used as an irrigation agent for intraurethral surgical irrigation to make the field of vision clear.
Specification:
Mannitol Injection | 3000ml:150g | Non PVC soft bags |
Founded in May 1998, Huaren Pharmaceutical is a modern pharmaceutical and health industry group integrating R&D, production and sales, focusing on medicine, health, medical equipment and medical services.
In August 2010, the company was successfully listed on the Shenzhen Stock Exchange, the stock abbreviation is "Huaren Pharmaceutical", stock code "300110". In July 2019, the company underwent a change of shareholding, and the management committee of Xi'an Qujiang New Area became the actual controller of the company.
After more than 20 years of development, the company's business focuses on nephrology, respiratory, fine hemp and large-volume preparations and other fields, and has successively built five production bases in Qingdao, Rizhao, Xiaogan, Pubei and Hefei, with a total production capacity of 950 million bags (bottles), and all production lines have passed the new GMP certification. The company's main products include small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices, tablets, capsules, powders, granules, supporting drug packaging, health products and APIs, etc., with a total of 98 varieties and 212 specifications of existing drugs, realizing the integrated development of "raw materials + preparations + pharmaceutical packaging materials".
In August 2010, the company was successfully listed on the Shenzhen Stock Exchange, the stock abbreviation is "Huaren Pharmaceutical", stock code "300110". In July 2019, the company underwent a change of shareholding, and the management committee of Xi'an Qujiang New Area became the actual controller of the company.
After more than 20 years of development, the company's business focuses on nephrology, respiratory, fine hemp and large-volume preparations and other fields, and has successively built five production bases in Qingdao, Rizhao, Xiaogan, Pubei and Hefei, with a total production capacity of 950 million bags (bottles), and all production lines have passed the new GMP certification. The company's main products include small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices, tablets, capsules, powders, granules, supporting drug packaging, health products and APIs, etc., with a total of 98 varieties and 212 specifications of existing drugs, realizing the integrated development of "raw materials + preparations + pharmaceutical packaging materials".
Pharmaceutical packaging materials,Rubber stoppers and APIs are self-produced and self-sold, the price is lower and the quality is more guaranteed.
- Similar Products
Negotiable
20000 Pieces (MOQ)
GMP Certified Ceftriaxone for Injection 0.25g
Reyoung Pharmaceutical Co., Ltd.
Negotiable
10000 Box (MOQ)
Gliclazide Tablets 80mg China Pharma GMP Supplier Factory
Ningbo Feiyue Trading Co., Ltd.